DSTDP Evaluation Team members Marion Carter and Dayne Collins presented the “Report-Back and Update on the STD AAPPS Program Outcome Measures (POM)” Webinar on June 23. This two-part webinar included a presentation of findings from the March 2015 POM submissions, where presenters summarized statistics and comparisons across project areas and described plans for further dissemination. For the second part of the webinar, DSTDP staff outlined guidance and rationale for the upcoming August 2015 POM submission, including changes to existing POM as well as new POM.
This webinar demonstrated the new STD Module of the National Electronic Disease Surveillance System Base System (NBS).
NBS provides reporting jurisdictions with a NEDSS-compatible information system to facilitate transferring health, laboratory, and clinical data efficiently and securely over the Internet. The demo focused on case management and other STD-specific features of the NBS. Staff from CDC’s Division of Health Informatics and Surveillance answered questions about the NBS STD Module development and implementation.
Community Approaches to Reducing Sexually Transmitted Diseases FOA - March 6, 2014
CDC’s Division of STD Prevention hosted a webinar about the new Community Approaches to Reducing Sexually Transmitted Diseases (CARs) Funding Opportunity Announcement (FOA).
For the CARS cooperative agreement, CDC will work with organizations to promote sexual health, advance community wellness, influence sexual health behavior and practices, and reduce STI disparities. The FOA provides support in the following five focus areas:
- Implementation of community engagement methods (e.g. community-based participatory research) to achieve health equity;
- Identification and implementation of systems and environmental change strategies that (a) promote sexual health and support healthy behaviors and (b) facilitate community-clinical linkages to build support for interventions to prevent and reduce STI disparities;
- Enhancement and sustainability of partnerships;
- Support for communication strategies to promote STD program successes and leverage additional resources for STI control and prevention; and
- Evaluation of the efficacy of this approach and intervention implementation.
National Network of STD Clinical Prevention Training Centers FOA Webinar - February 27, 2014
CDC’s Division of STD Prevention hosted a webinar Thursday, February 27th about the new funding opportunity announcement (FOA) for CDC-RFA-PS14-1407 National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC).
This FOA creates a National Network of STD Clinical Prevention Training Centers that will comprise up to eight regional (Component A) and six national (Component B) centers of excellence. The prevention training centers will develop, disseminate and evaluate training and training assistance to improve STD care at the individual health care clinician, clinical organization, and health care system levels. The overarching goal is to reduce population level STD burden throughout the United States. Training content and priorities for this FOA are based on the current CDC STD treatment guidelines, which encompass screening, treatment, and prevention of STDs, and are informed by STD epidemiological trends and scientific advancements. CDC staff provided general information to applicants about the FOA.
Third-Party Billing for Public Health STD Services: A Summary of Coordinated Needs Assessment - February 26, 2014
This webinar was based on information collected by the STD-related Reproductive Health, Prevention, Training, and Technical Assistance Centers. Andee Krasner, Region I STD TTAC Project Manager; Jennifer Kawatu, Region I STD TTAC Project Director; and Daryn Eikner, Director of Service Improvement at the Family Planning Council provided webinar participants with an overview of national data collected to better understand the current status and capacity for billing for STD services, training and technical assistance needs for STD-certified 340B clinics, state or project area STD programs, and state public health laboratories.
STD AAPPS Kickoff Meeting: Moving Forward in 2014 and Beyond - January 28, 2014
Staff from CDC’s Division of STD Prevention and the Procurement and Grants Office hosted “STD AAPPS Kickoff Meeting: Moving Forward in 2014 and Beyond,” a webinar for STD AAPPS grantees. Topics covered on this webinar included cooperative agreement monitoring, program consultant activities and assignments, PGO requirements, and how to request technical assistance.
Disease Intervention Services Training Centers FOA - November 8, 2013
Staff from CDC’s Division of STD Prevention and the Division of HIV/AIDS Prevention hosted a webinar about the new funding opportunity announcement (FOA) for STD/HIV Disease Intervention Services Training Centers (DISTC). CDC staff provided general information to applicants about the DISTC FOA.
Got County-level HIV and STD DATA? - September 17, 2013
You do now!!! Join CDC/NCHHSTP and NACCHO for a webcast featuring the latest innovations to CDC’s Atlas to help you better understand how to use county-level data and how to identify disparities (by race/ethnicity, sex, and age). Learn to create maps, tables, pie charts, bar graphs; explore data stratifications; display data trends over time and patterns across the United States; and download and export data and graphics.
Program Science: The Concept and Applications - August 20, 2013, Dr. Sevgi Aral, Associate Director of Science in CDC’s Division of STD Prevention provides webinar participants with general information about Program Science as a scientific focus; systems science as the core scientific discipline in Program Science; systems science methodologies; and Program Science Initiatives in the UK, Australia, and North America. Researchers, academia, and STD program staff will find this webinar of interest in their daily work.
Program evaluation, quality improvement, and performance management: Understanding how they relate and their role in public health programs - August 6, 2013, Presenters: Craig Thomas, Liza Corso, and Harold Pietz from CDC’s Office of State, Tribal, Local and Territorial Support (OSTLTS)
STD AAPPS Funding Opportunity Orientation, Q&A, and Evaluation - June 17 and 26 and July 11, 2013
The Revised Congenital Syphilis Report Form - What's New, Why, and How to Use It – April 29, 2013 with John R. Su, MD, Phd, MPH
Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the US - CDC Public Health Grand Rounds - February 19, 2013
- View recording, description and handout
- MMWR on CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease (January 31, 2014)
The Growing Threat of Multidrug-Resistant Gonorrhea – CDC Public Health Grand Rounds - May 15, 2012
- View recording, description and handout
- MMWR on CDC Grand Rounds: The Growing Threat of Multidrug-Resistant Gonorrhea (February 14, 2013)
Reverse Sequence Syphilis Screening Webinar - March 31, 2011
This webinar is for clinicians and 0ther health professionals who provide screening, diagnosis, and clinical care for persons at risk for or infected with syphilis.
The STD Treatment Guidelines were developed through a rigorous peer-review process to assist clinicians and healthcare providers in giving their patients the appropriate STD testing, treatment, and counseling messages. The 2015 STD Treatment Guidelines were released in June, and included updated testing, treatment, and diagnosis recommendations. Please join this webinar hosted by the U.S. Centers for Disease Control and Prevention’s Division of STD Prevention and the National Network of STD/HIV Prevention Training Centers to learn about these key changes.
Continuing education credits are available for this webinar. At the conclusion of the session, the participant will be able to accomplish the following:
- Discuss clinical significance of the STD prevention issue.
- Describe epidemiological trends related to the STD prevention issue.
- Identify key screening, treatment, and prevention recommendations for management of the STD prevention issue.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
The CE credits offered are:
CME: 1.5 hours
CNE: 1.5 hours
CEU: 0.2 hours
CECH: 1.5 hours
CPE: 0.15 hours
CDC’s Division of STD Prevention will host a webinar every month to discuss issues of interest to STD AAPPS grantees and those in STD programs at local and state health department. Webinar registration information will be posted on this page.
STD AAPPS awardees submitted their first set of program outcome measures to DSTDP in September 2014, covering the first 6 months of the award. Since then, the measures and initial results have been under review and minor and major changes are being planned for those measures. In this webinar, CDC staff shared highlights from that data submission. CDC staff also described the proposed changes, the rationale for changes, and what will be requested for March 2015 and beyond. CDC staff described the administrative requirements related to support for clinical preventive services under STD AAPPS, which CDC will request for March.
Dr. Matthew Hogben, Chief of the Social and Behavioral Research and Evaluation Branch, led the Partner Services assessment Webinar.
Those who attended the 2014 grantees meeting identified Partner Services as a priority intervention. As follow-up to this feedback, in this webinar Dr. Hogben will described a framework to assess partner services in STD control in 2014 – 2019. He also presented an overview of the pertinent literature and a data snapshot from current programs to characterize the process and outcome indicators of some partner services programs.
Following the presentation there was a discussion about possible approaches to improving Partner Services.
Dr. Jill Huppert, Program Development & Quality Improvement Branch (PDQIB) Branch Chief, and other DSTDP leadership presented the “STD-AAPPS Awardee Meeting Findings and Evaluation” webinar ton August 14, 2014. Presenters discussed findings and evaluation results from the STD-AAPPS awardee meeting sessions held at the 2014 STD Prevention Conference in June, 2014. Presenters shared a description of DSTDP’s plans to address the meeting findings and led a discussion of next steps to support STD-AAPPS outcomes. Webinar participants also had the opportunity to provide additional input regarding future AAPPS meetings.
CDC’s Division of STD Prevention hosted a webinar on July 8, 2014 about the new supplemental funding opportunity announcement (FOA) to STD AAPPS. This supplement will support enhanced program evaluation in a limited number of project areas over the next few years. Eligibility is limited to current awardees of STD AAPPS. This supplemental FOA focuses on evaluation of one or more of the following program strategies: 1) Use of assessment data for program decision-making, 2) Increasing CT screening in primary care settings, 3) Use of DIS for HIV-related outcomes, and 4) DIS contributions towards STD prevention more generally.
For the webinar, CDC staff provided general information to applicants about the enhanced program evaluation AAPPS FOA supplement.
- Webinar recording not available
- Webinar Slides
CDC’s Division of STD Prevention (DSTDP), in collaboration with the National Coalition of STD Directors (NCSD) and various project areas, have been developing program outcome measures for STD AAPPS. DSTDP staff described changes made to the measures in response to feedback and presented the latest set for 2014.
CDC’s Division of STD Prevention (DSTDP) hosted a webinar, “Laws and policy for AAPPS grantees”, on Thursday April 10, 2014. Lori Elmore, Lydia Poromon, and Ryan Cramer from DSTDP’s Office of Policy, Planning and External Relations, presented the webinar.
The presenters described the difference between policy and lobbying, introduce policy activities and deliverables under AAPPS, and provided examples of activities from state and local programs. The presenters also characterized the fundamentals of federal, state, and local lawmaking and provided an overview of state statutes concerning the prevention of sexually transmitted diseases.
DSTDP leadership discussed the STD Service GAP Analysis tool, guidance development, pilot activities, and lessons learned and shared guidance and examples from the Program Collaboration and Service Integration (PCSI) GAP analysis.
Participants learned about recommended practices for performing STD Service GAP analysis. Representatives from DSTDP commented on how the presentation’s content applies to the work that will be performed by the Division and its partners.
DSTDP leadership and staff described STD AAPPS awardee requirements in the first year of that award. They also provided an update on national outcome measures for AAPPS.
Participants will learn about proposed guidance for the Awardee Evaluation Plans. Representatives from DSTDP commented on how the presentation’s content applies to the work that will be performed by the Division and its partners.
The Centers for Disease Control and Prevention’s Division of STD Prevention and the American Sexually Transmitted Diseases Association have partnered to bring you the latest research and best practices for STD prevention with the STD Prevention Science Series.
It’s now well understood that social factors are a major determinant of HIV and other STDs. But how can we develop relevant interventions? And what are the methodological challenges of social determinants research? This talk explored how these issues can impact STD epidemiologic research among African-Americans.
Most of us appreciate the simple elegance of maps of STD cases or incidence rates. Maps are a straightforward surveillance tool, helping us to identify areas with the greatest disease burden. But can maps and related spatial methods do more for us? Can these tools provide insights into the underlying epidemiology of STDs and provide guidance for intervention? And are they really so simple, or can we sometimes mislead ourselves?
STDs Amplify the Transmission of HIV: Where do we go from here? - December 11, 2014, by Myron S. Cohen, M.D.
Since the time HIV was discovered as the cause of AIDS, we have known that a wide variety of STDs amplify transmission of the virus. The biological forces that create such risk are increasingly well understood. The greatest challenge has been to design strategies that link detection and treatment of STDs to reduced transmission of HIV.
This STD Prevention Science Series webinar explored that challenge.
Reconceptualizing Screening for Chlamydia Control: Process Considerations, Targets and Outcomes - September 25, 2014, by Edward W. Hook III, M.D.
STD Prevention Science Series - presented by CDC, Division of STD Prevention and the American Sexually Transmitted Disease Association (ASTDA)
Chlamydial infections are reported to be increasing in many developed nations, often despite control efforts using broad screening programs. These observations have been used to argue that such efforts are not an effective use of public health resources. In this presentation, chlamydia control efforts were considered using a sexually transmitted infection (STI) cascade perspective to demonstrate opportunities for improving current chlamydia screening efforts. In addition, we began to consider whether chlamydia rates represent the appropriate metric for assessing the impact of current chlamydia control efforts.
From Partner Services to Field Services: The Evolving Role of Public Health Outreach to Control HIV/STDs - March 13, 2014, by Matthew Golden, MD
Dr. Golden spoke about the evolving role of public health out¬reach in HIV/STD. Partner services have been a component of public health STD control since the 1940s, but were not initially widely employed to combat the HIV epidemic and were never adequately funded to meaningfully affect rates of chlamydial infection. The advent of expedited partner therapy for gonorrhea and chlamydial infection, a new national emphasis on the HIV care continuum, and HIV/STD program integration are now fundamentally altering the role of disease investigation and outreach in the control of HIV/STD, both in the U.S. and in low income nations.
Dr. Golden’s talk presented evidence supporting an expanded role for field outreach in the control of HIV/STD and discussed outstanding operational research questions that confront this area of public health practice.
Unpacking PID: Mysterious Microbes, Diagnostic Dilemmas and Triple Treatments - December 12, 2013, with Sharon L. Hillier, Ph.D.
Dr. Hillier will provide an update on new data describing the etiology of Pelvic Inflammatory Disease (PID), a condition that affects an estimated 750,000 women in the US yearly. While Chlamydia trachomatis and Neisseria gonorrhoeae are recognized as etiologic agents of PID, the data from recent studies of women having acute PID has demonstrated that fewer than half of women have one or both of these sexually transmitted pathogens. Most cases of nongonococcal, nonchlamydial PID are polymicrobial. Specifically, Atopobium vaginae, G vaginalis clade B, nontypeable Haemophilus influenzae, and other selected anaerobes are emerging as microorganisms which are present more frequently among women having histologically confirmed PID. These data have implications for the treatment of PID and prevention of infertility..
HIV Transmission Dynamics: From Viral Particles to Sexual Networks. Implications for HIV Prevention - September 19, 2013, with Thomas Quinn, MD, MS
Dr. Quinn reviewed the current epidemiological trends in the global AIDS pandemic and recent findings in the dynamics of viral transmission from both a viral and population level perspective. He discussed how this biomedical information can be incorporated in the implementation of combination preventions strategies in efforts to control this pandemic.
- View recording
- Information about the presentation and Dr. Celum
This educational activity can now be accessed as an educational resource but CME credit is no longer available.
- View recording
This educational activity can now be accessed as an educational resource but CME credit is no longer available.